Dr. Suraj Muley is a neurologist and internationally recognized expert in neuromuscular medicine, neuroimmunology, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy (CIDP). He serves as director of neurology at Bob Bové Neuroscience Institute at HonorHealth and is professor of medicine at Arizona State University School of Medicine and Advanced Medical Engineering. Dr. Muley completed his medical education at Seth Gordhandas Sunderdas Medical College, Mumbai, which was followed by research training in pharmacology and residency and fellowship training in neurology, clinical neurophysiology, and neuromuscular diseases at the University of Minnesota. He is board certified in neurology, clinical neurophysiology, and neuromuscular medicine.
Over a distinguished academic career spanning more than three decades, Dr. Muley has held major leadership roles at the University of Minnesota, Barrow Neurological Institute, and HonorHealth, including directing neuromuscular, neuroimmunology, fellowship, and residency programs. His clinical and research interests focus on immune-mediated neuromuscular disorders, with emphasis on novel targeted therapies for myasthenia gravis and CIDP. He has served as principal investigator or co-investigator on numerous national and international clinical trials in neuromuscular diseases.
Dr. Muley has authored and co-authored numerous peer-reviewed publications, book chapters, invited reviews, and international presentations in neuromuscular medicine. He is a Fellow of the American Academy of Neurology (FAAN), Fellow of the American College of Physicians (FACP), and Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin). His honors include multiple teaching and research awards.
Dr. Muley’s Fulbright-Nehru project is focusing on advancing neuromuscular medicine and neuroimmunology in India through collaborative teaching, research, and clinical training. Working with leading academic medical centers in Mumbai, his project emphasizes inflammatory neuropathies and myasthenia gravis, with particular focus on advanced electrophysiological techniques and emerging targeted therapies. The project aims to strengthen subspecialty education, promote collaborative clinical research, and develop sustainable academic partnerships between Indian and U.S. institutions. By leveraging India’s large and diverse patient population, the project seeks to improve understanding and treatment of immune-mediated neurological disorders while fostering long-term global collaboration in neuroscience.